RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $64,000 | -43.4% | 11,770 | 0.0% | 0.00% | – |
| Q4 2021 | $113,000 | -46.2% | 11,770 | 0.0% | 0.00% | – |
| Q3 2021 | $210,000 | -26.8% | 11,770 | 0.0% | 0.00% | – |
| Q2 2021 | $287,000 | -7.7% | 11,770 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $311,000 | -23.6% | 11,770 | -78.1% | 0.00% | 0.0% |
| Q4 2020 | $407,000 | +1.2% | 53,826 | -33.1% | 0.00% | 0.0% |
| Q3 2020 | $402,000 | +33.1% | 80,502 | +59.0% | 0.00% | 0.0% |
| Q2 2020 | $302,000 | -54.0% | 50,640 | -65.7% | 0.00% | -50.0% |
| Q1 2020 | $656,000 | – | 147,535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |